HomeGeneticsGeneSLC2A1 gene
Back to Gene
SLC2A1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

SLC2A1 gene

The SLC2A1 gene provides instructions for producing the GLUT1 protein, which is essential for transporting glucose into cells and across the blood-brain barrier.

Normal Function

The SLC2A1 gene provides instructions for producing a protein called the glucose transporter protein type 1 (GLUT1). The GLUT1 protein is embedded in the outer membrane surrounding cells, where it transports a simple sugar called glucose into cells from the blood or from other cells for use as fuel.

In the brain, the GLUT1 protein is involved in moving glucose, which is the brain's main energy source, across the blood-brain barrier. The blood-brain barrier acts as a boundary between tiny blood vessels (capillaries) and the surrounding brain tissue; it protects the brain's delicate nerve tissue by preventing many other types of molecules from entering the brain. The GLUT1 protein also moves glucose between cells in the brain called glia, which protect and maintain nerve cells (neurons).

Health Conditions Related to Genetic Changes

GLUT1 deficiency syndrome

More than 150 SLC2A1 gene mutations have been reported in people with GLUT1 deficiency syndrome. This disorder leads to a variety of neurological symptoms that can include:

  • Developmental delay
  • Intellectual disability
  • Movement problems
  • Frequent seizures (epilepsy)

The mutations that cause GLUT1 deficiency syndrome reduce or eliminate the function of the GLUT1 protein. Having less functional GLUT1 protein reduces the amount of glucose available to brain cells, which affects brain development and function.

Other Names for This Gene

  • DYT17
  • DYT18
  • DYT9
  • GLUT
  • GLUT1
  • GTR1_HUMAN
  • MGC141895
  • MGC141896
  • solute carrier family 2 (facilitated glucose transporter), member 1

Frequently Asked Questions

Parents or caregivers might observe developmental delays, intellectual disability, problems with movement coordination, and frequent seizures (epilepsy), often starting in infancy or early childhood. The severity and specific presentation of these symptoms can vary among individuals.
The primary treatment for GLUT1 deficiency syndrome is a ketogenic diet. This high-fat, low-carbohydrate diet forces the body to produce ketones, which can cross the blood-brain barrier and provide an alternative energy source for the brain when glucose transport is impaired. This can help reduce seizures and improve neurological symptoms.
Diagnosis usually involves a combination of tests. A key indicator is often a low glucose level in the cerebrospinal fluid (CSF) compared to blood glucose, measured via a lumbar puncture. Genetic testing of the SLC2A1 gene is then performed to confirm the presence of a mutation.
GLUT1 deficiency syndrome is typically inherited in an autosomal dominant pattern, meaning only one copy of the altered SLC2A1 gene is needed to cause the condition. However, many cases are "de novo" mutations, meaning they occur spontaneously in the affected individual and are not inherited from a parent. Genetic counseling can help determine the specific inheritance pattern in a family and assess recurrence risk.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA